SOCS3 and neoplasm: Of note, in vitro and in vivo studies conducted on SCC models showed that SOCS3 (and SOCS1) forced expression by SOCS3-derived peptide (KIR-ESS, see paragraph 4.1) efficiently suppresses IL-22-induced tumor growth (85).